Therapy Areas: Vaccines
17 January 2019 - Immuno-oncology company Targovax ASA (OSE:TRVX) revealed on Wednesday the receipt of the European patent that will protect its mutant-RAS specific neoantigen peptides, mutant RAS spe...
16 January 2019 - - US-based cancer immunotherapies developer CEL-SCI Corp. (NYSE American: CVM)  has received notification from the staff of the NYSE American, its current listing exchange,...
15 January 2019 - - The US Food and Drug Administration has approved the expanded use of Adacel (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed) to include rep...
15 January 2019 - - US-based biopharmaceutical research and development company CytRx Corp. (NASDAQ: CYTR) has highlighted that aldoxorubicin licensee NantCell, Inc., a private subsidiary of...
15 January 2019 - Biopharmaceutical company Sanofi reported on Monday the receipt of approval from the US Food and Drug Administration for the expanded use of Adacel (Tetanus Toxoid, Reduced Diphtheri...
11 January 2019 - - US-based biomedical company EpicGenetics has moved into a new facility that quadruples its capacity, the company said.

EpicGenetics developed and offers the FM/a Test...
Related Headlines